. . . . . . . . . . . . "[Until now, KIT has been considered an oncogenic driver and a potential therapeutic target.However, data presented by Dhal et al. show that in cutaneous melanomas the KIT promoter is a target for hypermethylation, leading to its downregulation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2016-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:51:14+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .